Viewing Study NCT05711212


Ignite Creation Date: 2025-12-18 @ 8:35 AM
Ignite Modification Date: 2025-12-18 @ 8:35 AM
Study NCT ID: NCT05711212
Status: None
Last Update Posted: 2024-05-28 00:00:00
First Post: 2023-01-24 00:00:00
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Effects of Xanthohumol on Resting Energy Expenditure and Substrate Oxidation in Healthy Women
Sponsor: None
Organization:

Study Overview

Official Title: Effects of Micellar Solubilized Xanthohumol on Resting Energy Expenditure and Substrate Oxidation in Healthy Women
Status: None
Status Verified Date: 2024-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: In a crossover design, 16 healthy young women ingest 172 mg micellar solubilized Xanthohumol or placebo in a randomized fashion. During an observational period of 3 hours, the acute effects of Xanthohumol on the resting energy expenditure and substrate oxidation is determined by respiratory gas analysis. An additional 30-minute determination of the resting energy expenditure and substrate oxidation is executed 24 hours after Xanthohumol ingestion. The wash-out period will be 28 days.
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: